SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-058189
Filing Date
2020-05-07
Accepted
2020-05-07 17:22:11
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2018774d1_s3.htm S-3 265511
2 EXHIBIT 5.1 tm2018774d1_ex5-1.htm EX-5.1 10567
3 EXHIBIT 23.1 tm2018774d1_ex23-1.htm EX-23.1 2449
4 GRAPHIC tm2018774d1_ex5-1img01.jpg GRAPHIC 5754
5 GRAPHIC tm2018774d1_s3img-01.jpg GRAPHIC 6963
6 GRAPHIC tm2018774d1_s3img-02.jpg GRAPHIC 6919
  Complete submission text file 0001104659-20-058189.txt   307245
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-238088 | Film No.: 20857708
SIC: 2834 Pharmaceutical Preparations